サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675388

静脈内療法・静脈アクセス市場：タイプ別、用途別、エンドユーザー別、地域別、2025-2033年

Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 144 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
静脈内療法・静脈アクセス市場：タイプ別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

静脈内療法・静脈アクセスの世界市場規模は2024年に263億米ドルに達しました。今後、IMARC Groupは、2033年までに同市場が395億米ドルに達し、2025～2033年の成長率（CAGR）は4.4%になると予測しています。慢性疾患の蔓延、交通事故の増加、点滴療法の利点に関する消費者の意識の高まりが、市場を牽引する主な要因のひとつです。

静脈内療法は、静脈を通じて血流に直接水分、薬剤、栄養を投与する医療処置です。この手技は、さまざまな症状や病気を治療するために、病院や診療所、その他の医療施設で一般的に使用されています。静脈アクセスとは、静脈内治療を行うために静脈に入ることです。医療専門家は通常、針を使用して皮膚を穿刺し、静脈にアクセスしますが、静脈が細い、または損傷している、脱水、肥満などの要因により、一部の患者さんには課題がある場合があります。点滴療法にはいくつかの種類があり、脱水症に対する生理食塩水、感染症に対する抗生物質、がん治療に対する化学療法などがあります。また、病状を治療するだけでなく、予防接種やビタミンの投与など、予防的な意味合いでも点滴療法が行われることがあります。

静脈内療法・静脈アクセスの市場動向：

がん、糖尿病、自己免疫疾患など、長期的な投薬とモニタリングを必要とする慢性疾患や生活習慣病の有病率の増加が、主に静脈内療法・静脈アクセス市場の世界の成長を牽引しています。このほか、交通事故の発生率の上昇や外傷症例の急増も市場成長に寄与しています。さらに、静脈内療法・静脈アクセスの利点に関する消費者の意識の高まりと重症患者治療の増加が、市場に有益な成長機会をもたらしています。これに伴い、低侵襲処置への嗜好が変化していることも、重要な成長促進要因として作用しています。これに加えて、必要な時間と労力を削減し、感染リスクを低下させ、手技の精度を向上させる医療業界における数々の技術的進歩が、市場に明るい展望を生み出しています。これと同時に、新たな治療法、薬剤、機器を革新するための研究開発（R&D）活動への広範な投資が、市場の拡大を後押ししています。さらに、医療支出の増加、病院数の増加、在宅医療の普及、高齢者人口の増加が、市場の成長を強化しています。

本レポートで扱う主な質問

  • 世界の静脈内療法・静脈アクセス市場はこれまでどのように推移してきたのか？
  • 世界の静脈内療法・静脈アクセス市場における市場促進要因、抑制要因、機会は何か？
  • それぞれの促進要因、抑制要因、機会が静脈内療法・静脈アクセスの世界市場に与える影響は？
  • 主要な地域市場とは？
  • 静脈内療法・静脈アクセス市場で最も魅力的な国は？
  • タイプ別の市場内訳は？
  • 静脈内療法・静脈アクセス市場で最も魅力的なタイプはどれですか？
  • 用途別の市場内訳は？
  • 静脈内療法・静脈アクセス市場で最も魅力的な用途はどれですか？
  • エンドユーザー別の市場内訳は？
  • 静脈内療法・静脈アクセス市場で最も魅力的なエンドユーザーは？
  • 世界の静脈内療法・静脈アクセス市場の競合構造は？
  • 静脈内療法・静脈アクセスの世界市場における主要企業/プレーヤーは？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の静脈内療法・静脈アクセス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 埋込みポート
  • 静脈カテーテル
  • 皮下注射針
  • 輸液ポンプ
  • その他

第7章 市場内訳：用途別

  • 栄養・緩衝液
  • ボリュームエキスパンダー
  • 投薬管理
  • 血液ベース製品

第8章 市場内訳：エンドユーザー別

  • 病院
  • 外来手術センター
  • クリニック

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AngioDynamics Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Fresenius SE & Co. KGaA
    • ICU Medical Inc.
    • Medtronic plc
    • Tekni-Plex Inc.
    • Teleflex Incorporated
    • Terumo Corporation
    • Vygon SAS
図表

List of Figures

  • Figure 1: Global: Intravenous Therapy and Vein Access Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Therapy and Vein Access Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Intravenous Therapy and Vein Access Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Intravenous Therapy and Vein Access Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Intravenous Therapy and Vein Access Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Intravenous Therapy and Vein Access Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Intravenous Therapy and Vein Access (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Intravenous Therapy and Vein Access (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Intravenous Therapy and Vein Access (Volume Expander) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Intravenous Therapy and Vein Access (Volume Expander) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Intravenous Therapy and Vein Access (Medication Administration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Intravenous Therapy and Vein Access (Medication Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Intravenous Therapy and Vein Access (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Intravenous Therapy and Vein Access (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Intravenous Therapy and Vein Access (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Intravenous Therapy and Vein Access (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Intravenous Therapy and Vein Access Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Intravenous Therapy and Vein Access Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Intravenous Therapy and Vein Access Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Intravenous Therapy and Vein Access Industry: Value Chain Analysis
  • Figure 83: Global: Intravenous Therapy and Vein Access Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Therapy and Vein Access Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Intravenous Therapy and Vein Access Market: Competitive Structure
  • Table 7: Global: Intravenous Therapy and Vein Access Market: Key Players
目次
Product Code: SR112025A7524

The global intravenous (IV) therapy and vein access market size reached USD 26.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.4% during 2025-2033. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.

Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.

Intravenous (IV) Therapy and Vein Access Market Trends:

The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.

Key Market Segmentation:

Type Insights:

  • Implantable Ports
  • Intravenous Catheters
  • Hypodermic Needles
  • Infusion Pumps
  • Others

Application Insights:

  • Nutrition and Buffer Solution
  • Volume Expander
  • Medication Administration
  • Blood Based Products

End User Insights:

  • Hospitals
  • Ambulatory Surgical Center
  • Clinics

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intravenous (IV) therapy and vein access. Some of the factors driving the North America intravenous (IV) therapy and vein access market included the growing prevalence of chronic diseases, the increasing number of road accidents, and the expanding geriatric population.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) therapy and vein access market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AngioDynamics Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, ICU Medical Inc., Medtronic plc, Tekni-Plex Inc., Teleflex Incorporated, Terumo Corporation, Vygon SAS, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global intravenous (IV) therapy and vein access market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global intravenous (IV) therapy and vein access market?
  • What is the impact of each driver, restraint, and opportunity on the global intravenous (IV) therapy and vein access market?
  • What are the key regional markets?
  • Which countries represent the most attractive intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the intravenous (IV) therapy and vein access market?
  • What is the competitive structure of the global intravenous (IV) therapy and vein access market?
  • Who are the key players/companies in the global intravenous (IV) therapy and vein access market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Therapy and Vein Access Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Implantable Ports
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravenous Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hypodermic Needles
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infusion Pumps
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Nutrition and Buffer Solution
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Volume Expander
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medication Administration
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Blood Based Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Center
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AngioDynamics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius SE & Co. KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 ICU Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Tekni-Plex Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Terumo Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vygon SAS
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.